Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iterum Therapeutics plc - Ordinary Share (NQ:ITRM)

0.5993 -0.0102 (-1.67%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 411,089
Open 0.6150
Bid (Size) 0.6028 (100)
Ask (Size) 0.6070 (100)
Prev. Close 0.6095
Today's Range 0.5912 - 0.6162
52wk Range 0.5719 - 3.020
Shares Outstanding 13,041,041
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top Stocks With Earnings This Week: Plug, Oklo, Circle And More
Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, Plug and Circle. 
Via Benzinga
ITRM Reports Results
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
-67.3%
-67.3%
1 Month
-17.9%
-17.9%
3 Month
-22.5%
-22.5%
6 Month
-36.1%
-36.1%
1 Year
-56.9%
-56.9%

More News

Read More
Iterum Therapeutics PLC (NASDAQ:ITRM) Reports Wider Q2 2025 Loss, Market Optimistic Ahead of ORLYNVAH Launch
Via Chartmill
Earnings Scheduled For August 5, 2025
Via Benzinga
Insights Ahead: Iterum Therapeutics's Quarterly Earnings
Via Benzinga
A Look Ahead: Iterum Therapeutics's Earnings Forecast
Via Benzinga
A Look at Iterum Therapeutics's Upcoming Earnings Report
Via Benzinga
Which stocks are moving after the closing bell on Monday?
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Top movers in Tuesday's pre-market session
Via Chartmill
Iterum Therapeutics's Earnings: A Preview
Via Benzinga
Earnings Scheduled For May 13, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?
Via Benzinga
Topics Economy World Trade
Earnings Scheduled For February 7, 2025
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
Via Benzinga
Earnings Scheduled For November 14, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 28, 2024
Via Benzinga

Frequently Asked Questions

Is Iterum Therapeutics plc - Ordinary Share publicly traded?
Yes, Iterum Therapeutics plc - Ordinary Share is publicly traded.
What exchange does Iterum Therapeutics plc - Ordinary Share trade on?
Iterum Therapeutics plc - Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Iterum Therapeutics plc - Ordinary Share?
The ticker symbol for Iterum Therapeutics plc - Ordinary Share is ITRM on the Nasdaq Stock Market
What is the current price of Iterum Therapeutics plc - Ordinary Share?
The current price of Iterum Therapeutics plc - Ordinary Share is 0.5993
When was Iterum Therapeutics plc - Ordinary Share last traded?
The last trade of Iterum Therapeutics plc - Ordinary Share was at 11/12/25 04:00 PM ET
What is the market capitalization of Iterum Therapeutics plc - Ordinary Share?
The market capitalization of Iterum Therapeutics plc - Ordinary Share is 7.82M
How many shares of Iterum Therapeutics plc - Ordinary Share are outstanding?
Iterum Therapeutics plc - Ordinary Share has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.